Global Microphysiological System and Organoids Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microphysiological System and Organoids Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Human Organ and Tissue Models
1.2.3 Disease Models
1.2.4 Non-Human Species Models
1.3 Market by Application
1.3.1 Global Microphysiological System and Organoids Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microphysiological System and Organoids Market Perspective (2021–2032)
2.2 Global Microphysiological System and Organoids Growth Trends by Region
2.2.1 Global Microphysiological System and Organoids Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microphysiological System and Organoids Historic Market Size by Region (2021–2026)
2.2.3 Microphysiological System and Organoids Forecasted Market Size by Region (2027–2032)
2.3 Microphysiological System and Organoids Market Dynamics
2.3.1 Microphysiological System and Organoids Industry Trends
2.3.2 Microphysiological System and Organoids Market Drivers
2.3.3 Microphysiological System and Organoids Market Challenges
2.3.4 Microphysiological System and Organoids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microphysiological System and Organoids Players by Revenue
3.1.1 Global Top Microphysiological System and Organoids Players by Revenue (2021–2026)
3.1.2 Global Microphysiological System and Organoids Revenue Market Share by Players (2021–2026)
3.2 Global Top Microphysiological System and Organoids Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microphysiological System and Organoids Revenue
3.4 Global Microphysiological System and Organoids Market Concentration Ratio
3.4.1 Global Microphysiological System and Organoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microphysiological System and Organoids Revenue in 2025
3.5 Global Key Players of Microphysiological System and Organoids Head Offices and Areas Served
3.6 Global Key Players of Microphysiological System and Organoids, Products and Applications
3.7 Global Key Players of Microphysiological System and Organoids, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microphysiological System and Organoids Breakdown Data by Type
4.1 Global Microphysiological System and Organoids Historic Market Size by Type (2021–2026)
4.2 Global Microphysiological System and Organoids Forecasted Market Size by Type (2027–2032)
5 Microphysiological System and Organoids Breakdown Data by Application
5.1 Global Microphysiological System and Organoids Historic Market Size by Application (2021–2026)
5.2 Global Microphysiological System and Organoids Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microphysiological System and Organoids Market Size (2021–2032)
6.2 North America Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microphysiological System and Organoids Market Size by Country (2021–2026)
6.4 North America Microphysiological System and Organoids Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microphysiological System and Organoids Market Size (2021–2032)
7.2 Europe Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microphysiological System and Organoids Market Size by Country (2021–2026)
7.4 Europe Microphysiological System and Organoids Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microphysiological System and Organoids Market Size (2021–2032)
8.2 Asia-Pacific Microphysiological System and Organoids Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microphysiological System and Organoids Market Size by Region (2021–2026)
8.4 Asia-Pacific Microphysiological System and Organoids Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microphysiological System and Organoids Market Size (2021–2032)
9.2 Latin America Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microphysiological System and Organoids Market Size by Country (2021–2026)
9.4 Latin America Microphysiological System and Organoids Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microphysiological System and Organoids Market Size (2021–2032)
10.2 Middle East & Africa Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microphysiological System and Organoids Market Size by Country (2021–2026)
10.4 Middle East & Africa Microphysiological System and Organoids Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Microphysiological System and Organoids Introduction
11.1.4 Emulate Revenue in Microphysiological System and Organoids Business (2021–2026)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Microphysiological System and Organoids Introduction
11.2.4 Mimetas Revenue in Microphysiological System and Organoids Business (2021–2026)
11.2.5 Mimetas Recent Development
11.3 InSphero
11.3.1 InSphero Company Details
11.3.2 InSphero Business Overview
11.3.3 InSphero Microphysiological System and Organoids Introduction
11.3.4 InSphero Revenue in Microphysiological System and Organoids Business (2021–2026)
11.3.5 InSphero Recent Development
11.4 TissUse
11.4.1 TissUse Company Details
11.4.2 TissUse Business Overview
11.4.3 TissUse Microphysiological System and Organoids Introduction
11.4.4 TissUse Revenue in Microphysiological System and Organoids Business (2021–2026)
11.4.5 TissUse Recent Development
11.5 CN Bio
11.5.1 CN Bio Company Details
11.5.2 CN Bio Business Overview
11.5.3 CN Bio Microphysiological System and Organoids Introduction
11.5.4 CN Bio Revenue in Microphysiological System and Organoids Business (2021–2026)
11.5.5 CN Bio Recent Development
11.6 Valo Health (TARA Biosystems)
11.6.1 Valo Health (TARA Biosystems) Company Details
11.6.2 Valo Health (TARA Biosystems) Business Overview
11.6.3 Valo Health (TARA Biosystems) Microphysiological System and Organoids Introduction
11.6.4 Valo Health (TARA Biosystems) Revenue in Microphysiological System and Organoids Business (2021–2026)
11.6.5 Valo Health (TARA Biosystems) Recent Development
11.7 Hesperos
11.7.1 Hesperos Company Details
11.7.2 Hesperos Business Overview
11.7.3 Hesperos Microphysiological System and Organoids Introduction
11.7.4 Hesperos Revenue in Microphysiological System and Organoids Business (2021–2026)
11.7.5 Hesperos Recent Development
11.8 TNO
11.8.1 TNO Company Details
11.8.2 TNO Business Overview
11.8.3 TNO Microphysiological System and Organoids Introduction
11.8.4 TNO Revenue in Microphysiological System and Organoids Business (2021–2026)
11.8.5 TNO Recent Development
11.9 AxoSim
11.9.1 AxoSim Company Details
11.9.2 AxoSim Business Overview
11.9.3 AxoSim Microphysiological System and Organoids Introduction
11.9.4 AxoSim Revenue in Microphysiological System and Organoids Business (2021–2026)
11.9.5 AxoSim Recent Development
11.10 Newcells Biotech
11.10.1 Newcells Biotech Company Details
11.10.2 Newcells Biotech Business Overview
11.10.3 Newcells Biotech Microphysiological System and Organoids Introduction
11.10.4 Newcells Biotech Revenue in Microphysiological System and Organoids Business (2021–2026)
11.10.5 Newcells Biotech Recent Development
11.11 Nortis
11.11.1 Nortis Company Details
11.11.2 Nortis Business Overview
11.11.3 Nortis Microphysiological System and Organoids Introduction
11.11.4 Nortis Revenue in Microphysiological System and Organoids Business (2021–2026)
11.11.5 Nortis Recent Development
11.12 Netri
11.12.1 Netri Company Details
11.12.2 Netri Business Overview
11.12.3 Netri Microphysiological System and Organoids Introduction
11.12.4 Netri Revenue in Microphysiological System and Organoids Business (2021–2026)
11.12.5 Netri Recent Development
11.13 Draper Laboratory
11.13.1 Draper Laboratory Company Details
11.13.2 Draper Laboratory Business Overview
11.13.3 Draper Laboratory Microphysiological System and Organoids Introduction
11.13.4 Draper Laboratory Revenue in Microphysiological System and Organoids Business (2021–2026)
11.13.5 Draper Laboratory Recent Development
11.14 Beijing Daxiang Biotech
11.14.1 Beijing Daxiang Biotech Company Details
11.14.2 Beijing Daxiang Biotech Business Overview
11.14.3 Beijing Daxiang Biotech Microphysiological System and Organoids Introduction
11.14.4 Beijing Daxiang Biotech Revenue in Microphysiological System and Organoids Business (2021–2026)
11.14.5 Beijing Daxiang Biotech Recent Development
11.15 Altis Biosystems
11.15.1 Altis Biosystems Company Details
11.15.2 Altis Biosystems Business Overview
11.15.3 Altis Biosystems Microphysiological System and Organoids Introduction
11.15.4 Altis Biosystems Revenue in Microphysiological System and Organoids Business (2021–2026)
11.15.5 Altis Biosystems Recent Development
11.16 Cherry Biotech
11.16.1 Cherry Biotech Company Details
11.16.2 Cherry Biotech Business Overview
11.16.3 Cherry Biotech Microphysiological System and Organoids Introduction
11.16.4 Cherry Biotech Revenue in Microphysiological System and Organoids Business (2021–2026)
11.16.5 Cherry Biotech Recent Development
11.17 Bi/ond
11.17.1 Bi/ond Company Details
11.17.2 Bi/ond Business Overview
11.17.3 Bi/ond Microphysiological System and Organoids Introduction
11.17.4 Bi/ond Revenue in Microphysiological System and Organoids Business (2021–2026)
11.17.5 Bi/ond Recent Development
11.18 Obatala Sciences
11.18.1 Obatala Sciences Company Details
11.18.2 Obatala Sciences Business Overview
11.18.3 Obatala Sciences Microphysiological System and Organoids Introduction
11.18.4 Obatala Sciences Revenue in Microphysiological System and Organoids Business (2021–2026)
11.18.5 Obatala Sciences Recent Development
11.19 Ananda Devices
11.19.1 Ananda Devices Company Details
11.19.2 Ananda Devices Business Overview
11.19.3 Ananda Devices Microphysiological System and Organoids Introduction
11.19.4 Ananda Devices Revenue in Microphysiological System and Organoids Business (2021–2026)
11.19.5 Ananda Devices Recent Development
11.20 ImmuONE
11.20.1 ImmuONE Company Details
11.20.2 ImmuONE Business Overview
11.20.3 ImmuONE Microphysiological System and Organoids Introduction
11.20.4 ImmuONE Revenue in Microphysiological System and Organoids Business (2021–2026)
11.20.5 ImmuONE Recent Development
11.21 React4life
11.21.1 React4life Company Details
11.21.2 React4life Business Overview
11.21.3 React4life Microphysiological System and Organoids Introduction
11.21.4 React4life Revenue in Microphysiological System and Organoids Business (2021–2026)
11.21.5 React4life Recent Development
11.22 AlveoliX
11.22.1 AlveoliX Company Details
11.22.2 AlveoliX Business Overview
11.22.3 AlveoliX Microphysiological System and Organoids Introduction
11.22.4 AlveoliX Revenue in Microphysiological System and Organoids Business (2021–2026)
11.22.5 AlveoliX Recent Development
11.23 BiomimX
11.23.1 BiomimX Company Details
11.23.2 BiomimX Business Overview
11.23.3 BiomimX Microphysiological System and Organoids Introduction
11.23.4 BiomimX Revenue in Microphysiological System and Organoids Business (2021–2026)
11.23.5 BiomimX Recent Development
11.24 Aracari Bio
11.24.1 Aracari Bio Company Details
11.24.2 Aracari Bio Business Overview
11.24.3 Aracari Bio Microphysiological System and Organoids Introduction
11.24.4 Aracari Bio Revenue in Microphysiological System and Organoids Business (2021–2026)
11.24.5 Aracari Bio Recent Development
11.25 StemPharm
11.25.1 StemPharm Company Details
11.25.2 StemPharm Business Overview
11.25.3 StemPharm Microphysiological System and Organoids Introduction
11.25.4 StemPharm Revenue in Microphysiological System and Organoids Business (2021–2026)
11.25.5 StemPharm Recent Development
11.26 SynVivo
11.26.1 SynVivo Company Details
11.26.2 SynVivo Business Overview
11.26.3 SynVivo Microphysiological System and Organoids Introduction
11.26.4 SynVivo Revenue in Microphysiological System and Organoids Business (2021–2026)
11.26.5 SynVivo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Microphysiological System and Organoids Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Human Organ and Tissue Models
Table 3. Key Players of Disease Models
Table 4. Key Players of Non-Human Species Models
Table 5. Global Microphysiological System and Organoids Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Microphysiological System and Organoids Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Microphysiological System and Organoids Market Size by Region (US$ Million), 2021–2026
Table 8. Global Microphysiological System and Organoids Market Share by Region (2021–2026)
Table 9. Global Microphysiological System and Organoids Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Microphysiological System and Organoids Market Share by Region (2027–2032)
Table 11. Microphysiological System and Organoids Market Trends
Table 12. Microphysiological System and Organoids Market Drivers
Table 13. Microphysiological System and Organoids Market Challenges
Table 14. Microphysiological System and Organoids Market Restraints
Table 15. Global Microphysiological System and Organoids Revenue by Players (US$ Million), 2021–2026
Table 16. Global Microphysiological System and Organoids Market Share by Players (2021–2026)
Table 17. Global Top Microphysiological System and Organoids Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microphysiological System and Organoids Revenue, 2025
Table 18. Ranking of Global Top Microphysiological System and Organoids Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Microphysiological System and Organoids Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Microphysiological System and Organoids, Headquarters and Area Served
Table 21. Global Key Players of Microphysiological System and Organoids, Products and Applications
Table 22. Global Key Players of Microphysiological System and Organoids, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Microphysiological System and Organoids Market Size by Type (US$ Million), 2021–2026
Table 25. Global Microphysiological System and Organoids Revenue Market Share by Type (2021–2026)
Table 26. Global Microphysiological System and Organoids Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Microphysiological System and Organoids Revenue Market Share by Type (2027–2032)
Table 28. Global Microphysiological System and Organoids Market Size by Application (US$ Million), 2021–2026
Table 29. Global Microphysiological System and Organoids Revenue Market Share by Application (2021–2026)
Table 30. Global Microphysiological System and Organoids Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Microphysiological System and Organoids Revenue Market Share by Application (2027–2032)
Table 32. North America Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026
Table 34. North America Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Microphysiological System and Organoids Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Microphysiological System and Organoids Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Microphysiological System and Organoids Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032
Table 47. Emulate Company Details
Table 48. Emulate Business Overview
Table 49. Emulate Microphysiological System and Organoids Product
Table 50. Emulate Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 51. Emulate Recent Development
Table 52. Mimetas Company Details
Table 53. Mimetas Business Overview
Table 54. Mimetas Microphysiological System and Organoids Product
Table 55. Mimetas Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 56. Mimetas Recent Development
Table 57. InSphero Company Details
Table 58. InSphero Business Overview
Table 59. InSphero Microphysiological System and Organoids Product
Table 60. InSphero Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 61. InSphero Recent Development
Table 62. TissUse Company Details
Table 63. TissUse Business Overview
Table 64. TissUse Microphysiological System and Organoids Product
Table 65. TissUse Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 66. TissUse Recent Development
Table 67. CN Bio Company Details
Table 68. CN Bio Business Overview
Table 69. CN Bio Microphysiological System and Organoids Product
Table 70. CN Bio Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 71. CN Bio Recent Development
Table 72. Valo Health (TARA Biosystems) Company Details
Table 73. Valo Health (TARA Biosystems) Business Overview
Table 74. Valo Health (TARA Biosystems) Microphysiological System and Organoids Product
Table 75. Valo Health (TARA Biosystems) Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 76. Valo Health (TARA Biosystems) Recent Development
Table 77. Hesperos Company Details
Table 78. Hesperos Business Overview
Table 79. Hesperos Microphysiological System and Organoids Product
Table 80. Hesperos Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 81. Hesperos Recent Development
Table 82. TNO Company Details
Table 83. TNO Business Overview
Table 84. TNO Microphysiological System and Organoids Product
Table 85. TNO Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 86. TNO Recent Development
Table 87. AxoSim Company Details
Table 88. AxoSim Business Overview
Table 89. AxoSim Microphysiological System and Organoids Product
Table 90. AxoSim Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 91. AxoSim Recent Development
Table 92. Newcells Biotech Company Details
Table 93. Newcells Biotech Business Overview
Table 94. Newcells Biotech Microphysiological System and Organoids Product
Table 95. Newcells Biotech Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 96. Newcells Biotech Recent Development
Table 97. Nortis Company Details
Table 98. Nortis Business Overview
Table 99. Nortis Microphysiological System and Organoids Product
Table 100. Nortis Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 101. Nortis Recent Development
Table 102. Netri Company Details
Table 103. Netri Business Overview
Table 104. Netri Microphysiological System and Organoids Product
Table 105. Netri Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 106. Netri Recent Development
Table 107. Draper Laboratory Company Details
Table 108. Draper Laboratory Business Overview
Table 109. Draper Laboratory Microphysiological System and Organoids Product
Table 110. Draper Laboratory Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 111. Draper Laboratory Recent Development
Table 112. Beijing Daxiang Biotech Company Details
Table 113. Beijing Daxiang Biotech Business Overview
Table 114. Beijing Daxiang Biotech Microphysiological System and Organoids Product
Table 115. Beijing Daxiang Biotech Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 116. Beijing Daxiang Biotech Recent Development
Table 117. Altis Biosystems Company Details
Table 118. Altis Biosystems Business Overview
Table 119. Altis Biosystems Microphysiological System and Organoids Product
Table 120. Altis Biosystems Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 121. Altis Biosystems Recent Development
Table 122. Cherry Biotech Company Details
Table 123. Cherry Biotech Business Overview
Table 124. Cherry Biotech Microphysiological System and Organoids Product
Table 125. Cherry Biotech Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 126. Cherry Biotech Recent Development
Table 127. Bi/ond Company Details
Table 128. Bi/ond Business Overview
Table 129. Bi/ond Microphysiological System and Organoids Product
Table 130. Bi/ond Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 131. Bi/ond Recent Development
Table 132. Obatala Sciences Company Details
Table 133. Obatala Sciences Business Overview
Table 134. Obatala Sciences Microphysiological System and Organoids Product
Table 135. Obatala Sciences Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 136. Obatala Sciences Recent Development
Table 137. Ananda Devices Company Details
Table 138. Ananda Devices Business Overview
Table 139. Ananda Devices Microphysiological System and Organoids Product
Table 140. Ananda Devices Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 141. Ananda Devices Recent Development
Table 142. ImmuONE Company Details
Table 143. ImmuONE Business Overview
Table 144. ImmuONE Microphysiological System and Organoids Product
Table 145. ImmuONE Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 146. ImmuONE Recent Development
Table 147. React4life Company Details
Table 148. React4life Business Overview
Table 149. React4life Microphysiological System and Organoids Product
Table 150. React4life Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 151. React4life Recent Development
Table 152. AlveoliX Company Details
Table 153. AlveoliX Business Overview
Table 154. AlveoliX Microphysiological System and Organoids Product
Table 155. AlveoliX Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 156. AlveoliX Recent Development
Table 157. BiomimX Company Details
Table 158. BiomimX Business Overview
Table 159. BiomimX Microphysiological System and Organoids Product
Table 160. BiomimX Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 161. BiomimX Recent Development
Table 162. Aracari Bio Company Details
Table 163. Aracari Bio Business Overview
Table 164. Aracari Bio Microphysiological System and Organoids Product
Table 165. Aracari Bio Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 166. Aracari Bio Recent Development
Table 167. StemPharm Company Details
Table 168. StemPharm Business Overview
Table 169. StemPharm Microphysiological System and Organoids Product
Table 170. StemPharm Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 171. StemPharm Recent Development
Table 172. SynVivo Company Details
Table 173. SynVivo Business Overview
Table 174. SynVivo Microphysiological System and Organoids Product
Table 175. SynVivo Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026
Table 176. SynVivo Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
Table 180. Authors List of This Report


List of Figures
Figure 1. Microphysiological System and Organoids Picture
Figure 2. Global Microphysiological System and Organoids Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Microphysiological System and Organoids Market Share by Type: 2025 vs 2032
Figure 4. Human Organ and Tissue Models Features
Figure 5. Disease Models Features
Figure 6. Non-Human Species Models Features
Figure 7. Global Microphysiological System and Organoids Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Microphysiological System and Organoids Market Share by Application: 2025 vs 2032
Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
Figure 10. Academic & Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Microphysiological System and Organoids Report Years Considered
Figure 13. Global Microphysiological System and Organoids Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Microphysiological System and Organoids Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Microphysiological System and Organoids Market Share by Region: 2025 vs 2032
Figure 16. Global Microphysiological System and Organoids Market Share by Players in 2025
Figure 17. Global Microphysiological System and Organoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Microphysiological System and Organoids Revenue in 2025
Figure 19. North America Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Microphysiological System and Organoids Market Share by Country (2021–2032)
Figure 21. United States Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Microphysiological System and Organoids Market Share by Country (2021–2032)
Figure 25. Germany Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Microphysiological System and Organoids Market Share by Region (2021–2032)
Figure 33. China Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Microphysiological System and Organoids Market Share by Country (2021–2032)
Figure 41. Mexico Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Microphysiological System and Organoids Market Share by Country (2021–2032)
Figure 45. Israel Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Emulate Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 49. Mimetas Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 50. InSphero Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 51. TissUse Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 52. CN Bio Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 53. Valo Health (TARA Biosystems) Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 54. Hesperos Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 55. TNO Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 56. AxoSim Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 57. Newcells Biotech Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 58. Nortis Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 59. Netri Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 60. Draper Laboratory Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 61. Beijing Daxiang Biotech Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 62. Altis Biosystems Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 63. Cherry Biotech Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 64. Bi/ond Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 65. Obatala Sciences Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 66. Ananda Devices Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 67. ImmuONE Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 68. React4life Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 69. AlveoliX Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 70. BiomimX Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 71. Aracari Bio Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 72. StemPharm Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 73. SynVivo Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit